Mary Dunn
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Co-authors
- Scott Antonia (5 shared papers)Mayer Fishman (5 shared papers)Dmitry I. Gabrilovich (5 shared papers)Ingo Fricke (2 shared papers)Noweeda Mirza (2 shared papers)Anthony Neuger (1 shared paper)Richard M. Lush (1 shared paper)Meredith Wallace Kazer (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Seminars in Oncology Nursing (3 papers)Journal of Immunotherapy (2 papers)Blood (2 papers)Urologic Oncology Seminars and Original Investigations (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Mary Dunn
25 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Immunology 531
- Oncology 519
- Hematology 75
- Pulmonary and Respiratory Medicine 149
- Genetics 48
Countries citing papers authored by Mary Dunn
This map shows the geographic impact of Mary Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Dunn more than expected).
Fields of papers citing papers by Mary Dunn
This network shows the impact of papers produced by Mary Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Dunn. The network helps show where Mary Dunn may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Dunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 443 | |
| 2 | 2011 | 93 | |
| 3 | 2021 | 93 | |
| 4 | 1989 | 65 | |
| 5 | 2015 | 58 | |
| 6 | 2008 | 52 | |
| 7 | 2016 | 41 | |
| 8 | 2006 | 35 | |
| 9 | 2012 | 34 | |
| 10 | 2010 | 31 | |
| 11 | 2018 | 28 | |
| 12 | 2017 | 21 | |
| 13 | 1977 | 15 | |
| 14 | 2015 | 13 | |
| 15 | 2024 | 12 | |
| 16 | 2021 | 10 | |
| 17 | 2015 | 6 | |
| 18 | 2021 | 5 | |
| 19 | 2019 | 5 | |
| 20 | 2005 | 4 |
About Mary Dunn
Mary Dunn is a scholar working on Oncology, Surgery, Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Bladder and Urothelial Cancer Treatments (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Prostate Cancer Treatment and Research (3 papers), Cancer Research and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (531 citations), Oncology (519 citations), Hematology (75 citations), Pulmonary and Respiratory Medicine (149 citations) and Genetics (48 citations). Mary Dunn has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Scott Antonia, Mayer Fishman, Dmitry I. Gabrilovich, Ingo Fricke, Noweeda Mirza, Anthony Neuger, Richard M. Lush, Meredith Wallace Kazer, Allison M. Deal and Matthew E. Nielsen. Their work appears in journals such as Journal of Clinical Oncology, Seminars in Oncology Nursing, Journal of Immunotherapy, Blood and Urologic Oncology Seminars and Original Investigations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.